How Strategic Partnerships Unlock Faster Enrollment, Greater Diversity, and Sustainable Growth
As clinical trial pipelines continue to expand, sponsors and CROs face a persistent challenge: the demand for high-performing sites is outpacing supply. Established research centers are increasingly saturated, investigator fatigue is rising, and enrollment timelines are under constant pressure.
The solution is not simply more sites—it’s the right sites, supported the right way.
Across the industry, there is growing recognition that emerging, community-based research sites can play a critical role in improving trial performance when they are thoughtfully developed and strategically partnered. At Medovation Clinical Research, we see this every day.
Rethinking “Emerging” Sites
Emerging research sites are often misunderstood as inexperienced or high-risk. In reality, many are established medical practices with:
- Deep, trusted relationships with their patient populations
- Physicians eager to engage in research but constrained by operational barriers
- Access to patients who are historically underrepresented in clinical trials
What holds these practices back is not capability—it’s infrastructure, support, and guidance.
When sponsors engage emerging sites without addressing these barriers, performance suffers. But when those same sites are supported through proven frameworks, centralized expertise, and hands-on operational execution, they can become top-performing contributors to a study.
The Sponsor Advantage: Why Emerging Sites Matter
Partnering with well-supported emerging sites offers tangible benefits for sponsors and CROs:
- Expanded Investigator Capacity
Only a small fraction of physicians currently participate in research, and many leave after a single trial due to operational strain. Supporting new investigators through structured onboarding and ongoing mentorship expands the investigator pool without increasing risk. - Faster, More Sustainable Enrollment
Community-based practices are where patients already receive care. When trials are embedded at the point of care, enrollment accelerates—often immediately—because trust already exists between physician and patient. - Meaningful Progress on Diversity Goals
Emerging sites are frequently located in communities that better reflect the real-world populations affected by disease. Partnering with these sites allows sponsors to move beyond aspirational diversity targets toward measurable, compliant representation. - Long-Term Site Reliability
Sites that are properly developed don’t just perform well once—they become repeat, reliable partners across multiple programs.
What Makes Emerging Sites Succeed
The difference between an underperforming new site and a high-impact one is intentional enablement.
At Medovation, emerging sites are never left to “figure it out.” Instead, we provide:
- Rigorous investigator and staff training led by experienced research leadership
- Standardized SOPs, playbooks, and startup frameworks
- Full wraparound operational support, including onsite CRC management
- Centralized oversight to ensure quality, compliance, and responsiveness
This model allows sponsors to gain access to new investigators and new patient populations—without sacrificing data quality, timelines, or confidence.
A Partnership Model Built for Today’s Trials
The future of clinical research depends on scalability, speed, and inclusivity. Emerging sites are essential to achieving all three—but only when sponsors move beyond transactional site selection and toward true partnership models.
By investing in the right support structures and working with organizations designed to operationalize community-based research, sponsors can:
- Reduce competition for oversubscribed sites
- Improve enrollment velocity
- Strengthen trial diversity
- Build a more resilient site network for the long term
At Medovation Clinical Research, our role is simple: remove the barriers that keep great physicians and willing patients out of research—and deliver results sponsors can trust.
Ready to Expand Your Site Strategy—Without Increasing Risk?
Sponsors and CROs don’t need more sites—they need the right sites, supported the right way.
At Medovation Clinical Research, we partner with community-based practices to deliver enrollment-ready investigators, diverse patient access, and operational excellence from day one.
Let’s talk about how emerging sites can strengthen your next study.
Contact us to explore partnership opportunities
Whether you’re planning an upcoming protocol or looking to optimize an active program, our team is ready to support your goals. Connect with our leadership team today:
Helen Combs, Co-Founder & CEO, h.combs@medovationresearch.com